Integrated Graphene, which pioneered the use of 3D graphene known as GiiTM to transform the human diagnostics and sustainable IoT sector, doubling its footprint to meet the growing global demand for Gii-based products and to increase R&D and production.
The company’s investment in growth supports the 19 high-skilled roles created in the last 12 months, representing a 63% headcount growth.
Based in Stirling, the expansion includes a new strategic base at Stirling University Innovation Park. This new facility will enable Integrated Graphene to run a fast and flexible prototype production line, increasing its annual Gii manufacturing capacity by 1000%. Current customers include global blue chip life sciences companies and world-leading academic institutions.
The new lab space will double the amount of R&D work that Integrated Graphene can do internally on its unique product portfolio and applications for Gii biosensing and power storage capabilities.
After the discovery of graphene in 2004, graphene was hailed as an extraordinary material for its potential in a number of industries and applications, from quantum computing to healthcare. In the biosensor market most companies use single-layer CVD graphene which is insufficiently reproducible, with too small a surface area and expensive to introduce into in-house deployable cost-effective assays.
Integrated Graphene has developed a unique breakthrough process to produce a pure sponge-like 3D carbon (Gii™) scaffold that has all the desired properties of graphene but suffers no scaling issues. Gii has potential applications for a wide range of industries including biosensors, internet of things (IOT), energy storage, pressure and gas sensors.
Graphene’s flagship integrated product, Gii-Sens™ is a biosensing electrode for human diagnostics that outperforms traditional sensing materials, enabling more cost-effective and repeatable assays to be developed with much higher sensitivities. The company is also in the advanced development stage of a new Gii-Cap™ supercapacitor that could significantly extend product life and dramatically reduce battery demand for IoT products.
Claus Marquordt, co-founder and CEO, Integrated Graphene said: “Scotland’s technology and life sciences sector is highly dynamic and we are proud to realize our expansion plans here in Stirling.
“Opening our facility at Stirling University Innovation Park will help us build on already strong academic relationships. We have only scratched the surface with the potential applications of Gii and look forward to intensifying the relationship with the University of Stirling and other academic partners to understand the further capabilities of our novel material.
“Having the capacity to scale our production to millions per year and state-of-the-art R&D operations will only increase the appeal of our products in key markets. As a diagnostic sensor component, for example, it has proven not only to be more sensitive but also more sustainable and lower cost, meaning it can provide faster and more accurate results for diagnosing all types of health conditions. This is a very exciting time for this business and we look forward to continuing to scale and commercialize it quickly.”
The addressable market for graphene-enabled products is potentially over $25 billion based on reasonable penetration rates across all markets, and volume demand for graphene across key application markets is expected to potentially reach $1+ trillion by 2030.